Dialiptin - M

Vildagliptin INN + Metformin Hydrochloride USP

Composition : Dialiptin-M 500: Metformin Hydrochloride +Vildagliptin (500mg+50mg) & Dialiptin-M 850 (850mg+50mg) Tablet.

Indication : It is indicated in the treatment of type 2 diabetes mellitus patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.

Dosage and administration :

Dialiptin-M 500: Max. vildagliptin daily dose: 100mg. Inadequately controlled on vildagliptin: Initially 50mg/500mg bid. Inadequately controlled on metformin HCl: one tablet bid. Switching from combination therapy of vildagliptin plus metformin HCl, as separate tab based from the dose of vildagliptin or metformin already being taken.

Dialiptin-M 850 Adult over 18 years: one tablet twice daily (based on patient's current metformin dose). Or, as directed by the registered physician.

Use in pregnancy and lactation : Dialiptin-M has been assigned to pregnancy category B by the FDA.ration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.

Packing :

Dialiptin-M 500: 2x7's tablets in blister pack.

Dialiptin-M 850: 2x7's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2022 Designed and Developed by ATI Limited.